Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 7/20 | 0.43 |
| ▸ | PLG | P00747 | 6/20 | 0.43 |
| ▸ | PLAT | P00750 | 2/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | F10 | P00742 | 3/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.36 |
| ▸ | XIAP | P98170 | 1/20 | 0.36 |
| ▸ | REN | P00797 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27553573 | 0.87 | PLG (0.44) | F2PLGPLATF10PRSS1 | |
| SCHEMBL31467762 | 0.87 | OPRM1 (0.44) | DPP4OPRM1EPHA2 | |
| SCHEMBL9450491 | 0.87 | OPRM1 (0.46) | F2DPP4OPRM1EPHA2XIAP | |
| SCHEMBL27532662 | 0.86 | F2 (0.57) | F2PLGF10PRSS1OPRM1 | |
| SCHEMBL7356254 | 0.86 | F2 (0.57) | F2PLGF10PRSS1OPRM1 | |
| SCHEMBL7356276 | 0.86 | F2 (0.57) | F2PLGF10PRSS1OPRM1 | |
| SCHEMBL6850997 | 0.86 | F2 (0.57) | F2PLGF10PRSS1OPRM1 | |
| SCHEMBL6850981 | 0.86 | F2 (0.57) | F2PLGF10PRSS1OPRM1 | |
| SCHEMBL27533421 | 0.85 | PLG (0.44) | F2PLGPLATF10PRSS1 | |
| Acetic Acid SCHEMBL10728075 | 0.85 | F2 (0.56) | F2PLGOPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993015756-A1 | INHIBITORS OF THROMBOSIS | CORVAS INTERNATIONAL, INC. (US) | 1993-08-19 | — | — | WO | disclosed |